Ray Dalio Medical Devices

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ABT Abbott Laboratories	$230B	$80.7 Million 0.47% of portfolio	707,615	Q3 2024 Reduced 57.59%
MDT Medtronic PLC	$121B	$52.5 Million 0.3% of portfolio	582,728	Q3 2024 Reduced 57.74%
BSX Boston Scientific Corp	$152B	$29.9 Million 0.17% of portfolio	356,764	Q3 2024 Reduced 69.56%
DXCM Dexcom Inc	$34.1B	$21.4 Million 0.12% of portfolio	319,629	Q3 2024 Reduced 7.97%
SYK Stryker Corp	$149B	$21.4 Million 0.12% of portfolio	59,238	Q3 2024 Reduced 80.69%
ZBH Zimmer Biomet Holdings, Inc.	$21.1B	$19.5 Million 0.11% of portfolio	180,627	Q3 2024 Reduced 48.62%
EW Edwards Lifesciences Corp	$44B	$10.9 Million 0.06% of portfolio	165,451	Q3 2024 Reduced 68.17%
ALGN Align Technology Inc	$16.6B	$9.01 Million 0.05% of portfolio	35,410	Q3 2024 Reduced 65.62%
STE Steris PLC	$22.4B	$3.82 Million 0.02% of portfolio	15,741	Q3 2024 Reduced 28.3%
SNN Smith & Nephew PLC	$10.8B	$2.88 Million 0.02% of portfolio	92,609	Q3 2024 Reduced 33.21%
PODD Insulet Corp	$19.8B	$2.59 Million 0.01% of portfolio	11,142	Q3 2024 Reduced 22.69%
GMED Globus Medical Inc	$6.73B	$2.35 Million 0.01% of portfolio	32,853	Q3 2024 Reduced 74.6%
AXNX Axonics, Inc.	$3.49B	$1.39 Million 0.01% of portfolio	20,016	Q3 2024 Reduced 53.04%
PEN Penumbra Inc	$9.89B	$1.12 Million 0.01% of portfolio	5,789	Q3 2024 Reduced 70.16%
GKOS Glaukos Corp	$7.14B	$1.09 Million 0.01% of portfolio	8,374	Q3 2024 Reduced 9.31%
TNDM Tandem Diabetes Care Inc	$2.26B	$1.09 Million 0.01% of portfolio	25,635	Q3 2024 Added 107.81%
UFPT Ufp Technologies Inc	$1.98B	$1.07 Million 0.01% of portfolio	3,388	Q3 2024 Reduced 43.3%
INSP Inspire Medical Systems, Inc.	$5.21B	$958,000 0.01% of portfolio	4,540	Q3 2024 Reduced 14.21%
TMDX Trans Medics Group, Inc.	$2.24B	$764,000 0.0% of portfolio	4,872	Q3 2024 Reduced 78.05%
IRTC I Rhythm Technologies, Inc.	$3.29B	$731,000 0.0% of portfolio	9,853	Q3 2024 Added 79.6%
ITGR Integer Holdings Corp	$4.62B	$661,000 0.0% of portfolio	5,088	Q3 2024 Reduced 68.78%
IART Integra Lifesciences Holdings Corp	$2.14B	$536,000 0.0% of portfolio	29,533	Q3 2024 Reduced 73.94%
AHCO Adapt Health Corp.	$1.23B	$457,000 0.0% of portfolio	40,742	Q3 2024 Reduced 50.47%
NARI Inari Medical, Inc.	$4.26B	$338,000 0.0% of portfolio	8,208	Q3 2024 Reduced 12.8%
AVNS Avanos Medical, Inc.	$772M	$251,000 0.0% of portfolio	10,471	Q3 2024 Reduced 35.1%

Shares Options

Ray Dalio

Ray Dalio is the founder and co-chief investment officer of Bridgewater Associates, one of the largest and most successful investment firms in the world. Dalio is known for his expertise in macroeconomic investing and his principles-based approach to decision making. He is also a well-known philanthropist and author.

Track Ray Dalio's portfolio

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account